User profiles for M. GENOVESE

marco genovese

- Verified email at inrim.it - Cited by 8640

Matthew Genovese

- Verified email at mail.utoronto.ca - Cited by 3245

Matteo Genovese

- Verified email at unical.it - Cited by 900

Research on hidden variable theories: A review of recent progresses

M Genovese - Physics Reports, 2005 - Elsevier
Quantum Mechanics (QM) is one of the pillars of modern physics: an impressive amount of
experiments have confirmed this theory and many technological applications are based on it. …

[PDF][PDF] Demyelinating and neurologic events reported in association with tumor necrosis factor α antagonism: by what mechanisms could tumor necrosis factor α …

WH Robinson, MC Genovese… - Arthritis & Rheumatism …, 2001 - academia.edu
Genovese and Moreland receive research funding from and have served as consultants
for Immunex, Seattle, Washington. Address correspondence and reprint requests to Mark C…

[HTML][HTML] Power-to-hydrogen and hydrogen-to-X energy systems for the industry of the future in Europe

M Genovese, A Schlüter, E Scionti, F Piraino… - International Journal of …, 2023 - Elsevier
The EU is promoting hydrogen as enabling energy carrier that may account for up to 20% of
energy and especially fulfill between 20% and 50% of transportation demands and between …

2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis

…, K Carandang, KD Deane, M Genovese… - Arthritis & …, 2021 - Wiley Online Library
Objective To develop updated guidelines for the pharmacologic management of rheumatoid
arthritis. Methods We developed clinically relevant population, intervention, comparator, …

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two‐year radiographic and clinical outcomes

MC Genovese, JM Bathon, RW Martin… - … : Official Journal of …, 2002 - Wiley Online Library
Genovese has received consultant fees from Immunex in the past, not connected with this
Genovese has received consultant fees from Immunex in the past, not connected with this …

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …

…, M Dougados, RA Furie, MC Genovese… - Arthritis & …, 2006 - Wiley Online Library
Genovese has received honoraria (less than $10,000 each) from Genentech, Biogen Idec, …
Genovese has received honoraria (less than $10,000 each) from Genentech, Biogen Idec, …

[HTML][HTML] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

…, MH Schiff, EC Keystone, MC Genovese… - … England Journal of …, 2000 - Mass Medical Soc
Background Etanercept, which blocks the action of tumor necrosis factor, reduces disease
activity in patients with long-standing rheumatoid arthritis. Its efficacy in reducing disease …

[HTML][HTML] Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition

MC Genovese, JC Becker, M Schiff… - … England Journal of …, 2005 - Mass Medical Soc
Background A substantial number of patients with rheumatoid arthritis have an inadequate
or unsustained response to tumor necrosis factor α (TNF-α) inhibitors. We conducted a …

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

…, E Alecock, T Woodworth, MC Genovese - Annals of the …, 2010 - ard.bmj.com
… MC Genovese10 … , and PREMIER trials.17 ,18 ,19 The objective of the AMBITION (Actemra
versus Methotrexate double-Blind Investigative Trial InmONotherapy) study was to compare …

Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs …

MC Genovese, JD McKay, EL Nasonov… - … : Official Journal of …, 2008 - Wiley Online Library
… drug therapy study - Genovese - 2008 - Arthritis & Rheumatism - Wiley Online Library …
Genovese had full access to all of the data in the study and takes responsibility for the …